Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Micrel, Inc. ("Micrel" or "the Company") (Nasdaq: MCRL) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Microchip Technology, Inc. ("Microchip").

Click here to learn more about the investigation, or call: 877-534-2590. There is no cost or obligation to you.

Under the terms of the transaction, Micrel shareholders will receive only $14.00 in cash or Microchip stock for each share of Micrel stock they own. The investigation concerns whether the Board of Micrel breached their fiduciary duties to shareholders and whether Microchip is underpaying for Micrel. The transaction may undervalue Micrel and would result in a loss for many Micrel shareholders. For example, an analyst has placed a $18.00 per share price target on Micrel stock and shares of Micrel stock traded at $15.63 on March 23, 2015.

If you own shares of Micrel and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA 19004, by visiting, or calling toll free 877-LEGAL-90.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

View source version on

Copyright Business Wire 2010